Winlevi (clascoterone, Sun Pharma), approved in August 2020 for hormonal acne, is a good option, Tolkachjov said, as it targets specifically the hormonal type of acne that we think is going on here due to the weight changes. As dermatologists treat GLP-1 receptor agonist-induced acne, Tolkachjov encourages practitioners to communicate this possible side effect to their patients moving forward
In advance of availability, Novo Nordisk is actively sharing clear, timely information with patients, caregivers, and healthcare professionals about the name change from Rybelsus to the Ozempic pill, its dosage strengths, and what people can expect at the pharmacy in May
They are pricing their options the way they would any major household expense, and the market, from manufacturers to telehealth platforms to benefits designers, is reorganizing itself around that new, more skeptical consumer
we offer personalized consultations to discuss how the medication affects your specific biology